Sector portfolio · VC firm · United States

Wellington Management's Biotech portfolio

Wellington Management has backed 62 Biotech startups in rounds we track, $16B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

62startups backed
4stages
$16Braised between them
Series C and laterbiggest stage

Wellington Management's whole portfolioWellington Management's profile

Series C and later

27

+3 more

Series B

14

Stage not reported

13

Series A

8

Segment by segment

Series C and later

27 startups · $7.9B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
  3. Avidity BiosciencesSynapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.United States$790M
  4. ModernaLearn how we’re changing the world of medicine.United States$675M
  5. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  6. TubulisTubulis is a chemotherapeutic medication developer specializing in cancer and chronic disease treatment.Germany$401M
  7. GalectoGalecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.Denmark$365M
  8. AAtrecaAtreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.United States$313M

Series B

14 startups · $2.5B raised

  1. Artiva BiotherapeuticsArtiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.United States$420M
  2. Global Blood TherapeuticsGBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.United States$389M
  3. Voyager TherapeuticsVoyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.United States$205M
  4. Upstream BioUpstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.United States$200M
  5. Gracell BiotechnologiesGracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.China$185M
  6. Generation BioGeneration Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.United States$176M
  7. Neon TherapeuticsNEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.United States$161M
  8. Black Diamond TherapeuticsBlack Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.United States$160M

Stage not reported

13 startups · $3.5B raised

  1. Apogee TherapeuticsApogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.United States$1.3B
  2. NuvalentNuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.United States$500M
  3. Centessa PharmaceuticalsCentessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.United States$250M
  4. Nurix TherapeuticsNurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.United States$250M
  5. Vets First ChoiceVets First Choice provides veterinary practices with an online pharmacy and home delivery services.United States$227M
  6. Cogent BiosciencesCogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.United States$200M
  7. Crescent BiopharmaCrescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.United States$185M
  8. Acrivon TherapeuticsAcrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.United States$130M

Series A

8 startups · $2.6B raised

  1. Dyne TherapeuticsDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.United States$828M
  2. Nuvation BioNuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.United States$675M
  3. Rhythm PharmaceuticalsRhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeuticsUnited States$311M
  4. Disc MedicineDisc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.United States$275M
  5. Verve TherapeuticsVerve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.United States$202M
  6. GTGemini TherapeuticsGemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.United States$138M
  7. Satsuma PharmaceuticalsSatsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.United States$92M
  8. CarismaCarisma is a provider of outsourced managed IT services.United States$53M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Wellington Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioWellington Management's AI portfolio26 startups · $67BSector portfolioWellington Management's Fintech portfolio22 startups · $15BSector portfolioWellington Management's Healthtech portfolio12 startups · $3.2BSector portfolioWellington Management's Pharma portfolio11 startups · $2.2BCo-investorsWho invests with Wellington Management257 co-investorsPortfolio mapWellington Management portfolio map170 startups · $127B

Raising from investors like Wellington Management?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps